# This will also be the largest overseas purchase by an Indian company after Corus was taken over by Tata Steel in April 2007.

*business, biotech · news · 2026-04-27 · The Economic Times*

## Key points

- Sun Pharmaceutical is set to acquire Organon & Co for approximately $12.5 billion in its biggest deal.
- Sun will pay $4.5 billion in equity and assume Organon's $8.5 billion debt in the transaction.
- Organon's board selected Sun over a rival EQT-Grünenthal consortium as the preferred bidder.
- Sun Pharma incorporated Sun Pharma America Inc. on Friday, likely as the acquisition vehicle for this deal.
- Aalok Shanghvi, executive chairman’s son, is expected to relocate to the US post-acquisition completion.

**Companies:** Sun Pharmaceutical Industries, Organon & Co, JP Morgan, MUFG, Citi, McKinsey & Co
**Countries:** India, United States

[Read the full story on The Economic Times](https://economictimes.indiatimes.com/epaper/delhicapital/2026/apr/27/et-front/sun-pharma-set-to-buy-organon-for-12-5-billion/articleshow/130543310.cms)

---

Canonical: https://newsio.io/n/d73a3be7-e828-4b5d-a007-61bd54892f8b/this-will-also-be-the-largest-overseas-purchase-by-an-indian-company-after-corus
Summarized by Newsio from The Economic Times. https://newsio.io/how-it-works